The Universal Immunisation Programme is one of the largest vaccination projects in the world aimed at protecting children and pregnant mothers from preventable diseases. Under it, the government provides shots for 12 vaccine-preventable diseases, such as polio, diphtheria, tetanus, measles, and hepatitis B, for free.
Microsoft Chairman and CEO Satya Nadella along with Alphabet Inc and its subsidiary Google CEO Sundararajan Pichai are also among those from trade and industry who have been awarded the Padma Bhushan for their distinguished services.
By 2022, there is a plan to make an mRNA-technology vaccine, for which it has tied up with Canadian firm Providence Therapeutics.
Union Health Minister Harsh Vardhan on Friday said the COVID-19 vaccination drive will be extended in the coming days and asserted that there should not be any misconceptions about the two Indian vaccines being administered in the country.
The Covishield maker's forte throughout the past half a century has been a combination of affordable vaccines and high volumes. Its tetanus, diphtheria and measles vaccines are known throughout the world, reports Sohini Das.
India, which has shipped 'Made In India' COVID-19 vaccines to around 25 nations, on Wednesday urged the international community to stop 'vaccine nationalism' and actively encourage 'internationalism', underlining that hoarding superfluous doses will defeat global efforts to attain collective health security and combat the pandemic.
'Even if Serum Institute and Bharat Biotech were successful in ramping up production overnight, what happens to the capacity after the demand from India is met?' asks Sanjeev Nayyar.
Covishield vaccine production won't be hit due to the fire, Serum Institute of India Chief Executive Officer Adar Poonawalla said. The Manjari facility is where the Covishield vaccine used in the nationwide inoculation drive against the pandemic is made.
'At the stage where we are in today in the country, by the time mass vaccination becomes available, it would be around the middle of next year.' 'Most of those people, who got infected this year, will be next year back to level zero -- once again susceptible.'
'We need to have the courage to take a rational look at known facts and act accordingly,' advises Mohan Guruswamy.
'People are already sending congratulatory messages. But I have said, "Please don't until the trials are over".'
'We know there will be an end to this epidemic temporarily.' 'We probably should get a couple of years break before it comes again.'
Lives "will once again be at risk" if funding is not urgently secured, United Nations officials have said on the eve of the first anniversary of a military crackdown that forced them to flee their country.
Putin said India will become a full-fledged member of the SCO in a week.
Eating healthy, exercising, not smoking and drinking are the most common pregnancy rules. But here are some more...
Adults are as likely as children to fall prey to diseases that immunisation can potentially prevent.
Gates, who is to attend the World Economic Forum's Annual Meeting, on Monday said there is reason to be optimistic than ever about the future progress using vaccines to give all children a healthy start to life.
The biotech company's revenues had fallen to as low as Rs 50 cr.
According to the petitioner, P G Hari, who is a homoeopathy practitioner in Wayanad and president of the 'Jankeeya Manushyavakasasamrakhana Prasthanam' (Organisation Fighting for Protection of People's Rights), "adverse effects" of the vaccine had been reported from Sri Lanka, Bhutan and Bangladesh and no proper studies were conducted before it was introduced in India
HLL's ability to enter a new biz and its track record augur well for the challenge
"We have a cash balance of close to Rs 1,500 crore. A majority of this balance can be used for acquisitions as our annual working capital requirement is only Rs 25-30 crore. I will not rule out a buyout of companies to expand our domestic business," said Mernosh Kapadia, senior executive director, GSK India. It is speculated that GlaxoSmithKline Plc is in talks to acquire leading Indian drug major Piramal Healthcare, in a deal valued over $1.5 billion.
After blaming the Centre for the drought as well as the floods in the state, the Mayawati-led Uttar Pradesh government has now held the United Progressive Alliance-led government responsible for the spread of various diseases in the state.UP Health Minister Anant Kumar Misra on Tuesday blamed the Centre for the spread of encephalitis, malaria, measles and other vector-borne diseases, which were threatening to turn into an epidemic.
What you need to know to stay healthy when you're travelling.
Amid reports of a US Congress probe against India's largest drug maker Ranbaxy Laboratories, data show that many leading multinational companies such as Pfizer, GlaxoSmithKline, Novartis and Merck are also under the scanner of the US drug regulator, for more or less similar violations as Ranbaxy is alleged to have committed.
Shantha Biotechnics Ltd on Friday announced the availability of 'Shantetra', a combination vaccine against diphtheria, tetanus, pertussis and hepatitis-B, claimed to be the first indigenously developed four-in-one immunity shot.
© 2025 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances